{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:48:33Z","timestamp":1778662113430,"version":"3.51.4"},"reference-count":45,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,10,25]]},"abstract":"<jats:p>Background: Glucose metabolism and insulin signaling alterations play an important role in Alzheimer\u2019s disease (AD) pathogenesis. Researchers have extensively attempted to characterize the exact pathophysiological mechanisms in the cerebrospinal fluid (CSF), as evidence concerning this fluid biomarkers is expected to enhance AD diagnosis\u2019 specificity and accuracy and serve as an early disease detection tool. There is controversy about insulin levels in the CSF relationship with mild cognitive impairment (MCI) and AD. Objective: This systematic review provides an overview of the state-of-the-art knowledge about insulin-related CSF biomarkers in AD and MCI. Methods: We performed a qualitative systematic literature review of reported data of CSF glucose, insulin, or insulin-related molecules in humans with AD or MCI, consulting the electronic databases Medline, Scopus, Web of Science, Cochrane, and BASE until May 2022. Results: We selected 19 studies, 10 of them reporting data on CSF insulin and 8 on insulin-related molecules like growth factors or their binding proteins. They predominantly found decreased levels of CSF insulin and increased levels of CSF insulin-related growth factors and their binding proteins. Conclusion: Due to the studies\u2019 protocols and results heterogeneity, we recommend a larger database of clinical trials with similar characteristics for a better understanding of this relationship.<\/jats:p>","DOI":"10.3233\/jad-220688","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T11:53:13Z","timestamp":1662465193000},"page":"1-13","source":"Crossref","is-referenced-by-count":5,"title":["Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer\u2019s Disease: A Systematic Review1"],"prefix":"10.1177","volume":"90","author":[{"given":"Elena","family":"Sag\u00fces-Ses\u00e9","sequence":"first","affiliation":[{"name":"Facultad de Medicina, Universidad de M\u00e1laga, M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Rioja","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad de M\u00e1laga, M\u00e1laga, Spain"},{"name":"Centro de Investigaciones M\u00e9dico-Sanitarias (CIMES), M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Garz\u00f3n-Maldonado","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"},{"name":"Departamento de Neurolog\u00eda, Hospital Universitario Virgen de la Victoria de M\u00e1laga, M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Narv\u00e1ez","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad de M\u00e1laga, M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Garc\u00eda-Arn\u00e9s","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad de M\u00e1laga, M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Garc\u00eda-Casares","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad de M\u00e1laga, M\u00e1laga, Spain"},{"name":"Centro de Investigaciones M\u00e9dico-Sanitarias (CIMES), M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220688_ref1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/cjn.2016.36","article-title":"The prevalence and incidence of dementia due to Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"43","author":"Fiest","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-220688_ref2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neubiorev.2021.07.007","article-title":"Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"128","author":"Qu","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-220688_ref3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-019-0474-3","article-title":"Brief cognitive screening instruments for early detection of Alzheimer\u2019s disease: A systematic review","volume":"11","author":"Elisa De Roeck","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220688_ref4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12014-020-09276-9","article-title":"A comprehensive systematic review of CSF proteins and peptides that define Alzheimer\u2019s disease","volume":"17","author":"Pedrero-Prieto","year":"2020","journal-title":"Clin Proteom"},{"key":"10.3233\/JAD-220688_ref5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease","volume":"11","author":"Van der Velpen","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220688_ref6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease NIH Public Access","volume":"7","author":"Mckhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220688_ref7","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1586\/ern.10.136","article-title":"Cerebral glucose metabolism in preclinical and prodromal Alzheimer\u2019s disease","volume":"10","author":"Herholz","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-220688_ref8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer\u2019s disease: Cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-220688_ref9","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/ijms21093165","article-title":"Molecular sciences type 3 diabetes and its role implications in Alzheimer\u2019s disease","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-220688_ref10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00592-013-0546-y","article-title":"Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans","volume":"51","author":"Heni","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.3233\/JAD-220688_ref11","first-page":"168","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: Concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Neurol"},{"key":"10.3233\/JAD-220688_ref12","doi-asserted-by":"crossref","first-page":"e0126804","DOI":"10.1371\/journal.pone.0126804","article-title":"The brain response to peripheral insulin declines with age: A contribution of the blood-brain barrier?","volume":"10","author":"Sartorius","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220688_ref13","doi-asserted-by":"crossref","first-page":"25589","DOI":"10.1038\/srep25589","article-title":"Type 3 diabetes: Cross talk between differentially regulated proteins of type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"6","author":"Mittal","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220688_ref14","first-page":"128","article-title":"CSF andbrain indices of insulin resistance, oxidative stress andneuro-inflammation in early versus late Alzheimer\u2019s disease","volume":"3","author":"Lee","year":"2013","journal-title":"JAlzheimers Dis Parkinsonism"},{"key":"10.3233\/JAD-220688_ref15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JAD-180906","article-title":"Early-stage Alzheimer\u2019s disease is associated with simultaneous systemic and central nervous system dysregulation of insulin-linked metabolic pathways","volume":"68","author":"De La Monte","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/JAD-2010-100795","article-title":"Insulin levels are decreased in the cerebrospinal fluid of women with prodromal Alzheimer\u2019s disease","volume":"22","author":"Gil-Bea","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease Relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-220688_ref18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2012.01.017","article-title":"Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms","volume":"510","author":"Besga","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220688_ref19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3233\/JAD-150351","article-title":"Increased cerebrospinal fluid level of insulin-like growth factor-II in male patients with Alzheimer\u2019s disease","volume":"48","author":"\u212bberg","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.psyneuen.2013.02.006","article-title":"Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in alzheimer\u2019s disease","volume":"38","author":"Johansson","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.3233\/JAD-220688_ref21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2377-14-64","article-title":"Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer\u2019s disease: An observational study","volume":"14","author":"Hertze","year":"2014","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-220688_ref22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/JAD-190921","article-title":"Patients with Alzheimer\u2019s disease have increased levels of insulin-like growth factor-I in serum but not in cerebrospinal fluid","volume":"75","author":"Horvath","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/biof.5520330202","article-title":"Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer\u2019s disease","volume":"33","author":"Salehi","year":"2008","journal-title":"BioFactors"},{"key":"10.3233\/JAD-220688_ref24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02257671","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type","volume":"5","author":"Tham","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.3233\/JAD-220688_ref25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1600-0447.1988.tb05193.x","article-title":"Insulin-like growth factors and somatomedin B in the cerebrospinal fluid of patients with dementia of the Alzheimer type","volume":"77","author":"Tham","year":"1998","journal-title":"Act Psychiatr Scand"},{"key":"10.3233\/JAD-220688_ref26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-170263","article-title":"Peripheral versus central index of metabolic dysfunction and associations with clinical and pathological outcomes in Alzheimer\u2019s disease","volume":"60","author":"McLimans","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/JAD-141902","article-title":"Alzheimer amyloid peptide A\u03b242 regulates gene expression of transcription and growth factors","volume":"44","author":"Barucker","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-170522","article-title":"Association of cerebrospinal fluid (CSF) insulin with cognitive performance and CSF biomarkers of Alzheimer\u2019s disease","volume":"61","author":"Geijselaers","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1034\/j.1600-0404.2002.01326.x","article-title":"Cerebrospinal fluid levels of insulin in patients with Alzheimer\u2019sdisease","volume":"106","author":"Molina","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-220688_ref30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0006-3223(91)90158-I","article-title":"Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type","volume":"30","author":"Fujisawa","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-220688_ref31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamasurg.2021.0546","article-title":"PRISMA reporting guidelines for meta-analyses and systematic reviews","volume":"156","author":"Shipra","year":"2021","journal-title":"JAMA Surg"},{"key":"10.3233\/JAD-220688_ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijdevneu.2017.02.008","article-title":"Insulin deficiency: A possible link between obesity and cognitive function","volume":"59","author":"Nameni","year":"2017","journal-title":"Int J Dev Neurosci"},{"key":"10.3233\/JAD-220688_ref33","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1007\/s00125-006-0409-y","article-title":"Low cerebrospinal fluid insulin levels in obese humans","volume":"49","author":"Kern","year":"2006","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-220688_ref34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2017.04.033","article-title":"Effects of age and glucose levels on lactate levels in cerebrospinal fluid examination of neurodegenerative diseases.","volume":"378","author":"Nakano","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-220688_ref35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0304-3940(95)12058-C","article-title":"Increased cerebrospinal fluid pyruvate levels in Alzheimer\u2019s disease","volume":"199","author":"Parnetti","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220688_ref36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3233\/JAD-2011-111007","article-title":"CSF A\u03b21-42 levels and glucose metabolism in Alzheimer\u2019s disease","volume":"27","author":"Dumurgier","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref37","doi-asserted-by":"crossref","first-page":"104755","DOI":"10.1016\/j.nbd.2020.104755","article-title":"ApoE and cerebral insulin:Trafficking, receptors, and resistance.","volume":"137","author":"Rhea","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-220688_ref38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-220688_ref39","doi-asserted-by":"crossref","first-page":"e0155733","DOI":"10.1371\/journal.pone.0155733","article-title":"Meta-analysis of serum insulin-like growth factor 1 in Alzheimer\u2019s disease","volume":"11","author":"Ostrowski","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220688_ref40","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10072-016-2655-1","article-title":"Circulating insulin-like growth factor 1 and insulin-like growth factor binding protein-3 level in Alzheimer\u2019s disease: A meta-analysis","volume":"37","author":"Hu","year":"2016","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-220688_ref41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/156720501303160217111434","article-title":"Peripheral blood adipokines and insulin levels in patients with Alzheimer\u2019s disease: A replication study and meta-analysis","volume":"13","author":"Ma","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-220688_ref42","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3233\/JAD-210516","article-title":"Decreased levels of insulin-like growth factor-1 are associated with Alzheimer\u2019s disease: A meta-analysis","volume":"82","author":"Xu","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220688_ref43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000510677","article-title":"Antidiabetic drugs in Alzheimer\u2019s disease and mild cognitive impairment: A systematic review","volume":"49","author":"Mun\u00f5z-Jim\u00e9nez","year":"2021","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-220688_ref44","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00415-018-8768-0","article-title":"Intranasal insulin in Alzheimer\u2019s dementia or mild cognitive impairment: A systematic review","volume":"265","author":"Avgerinos","year":"2018","journal-title":"J Neurol"},{"key":"10.3233\/JAD-220688_ref45","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1097\/MJT.0000000000000926","article-title":"Efficacy of intranasal insulin in improving cognition in mild cognitive impairment and Alzheimer disease: A systematic review and meta-analysis","volume":"26","author":"Lu","year":"2019","journal-title":"Arm J Ther"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:33Z","timestamp":1777370853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":45,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-220688","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}